Ignite Creation Date:
2025-12-25 @ 3:05 AM
Ignite Modification Date:
2026-05-22 @ 8:04 AM
Study NCT ID:
NCT02817633
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-28
First Post:
2016-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Sponsor:
Tesaro, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasms | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | TSR-022 | View |
| None | Nivolumab | View |
| None | Advanced solid tumors | View |
| None | Metastatic solid tumors | View |
| None | Immunotherapy | View |
| None | Colorectal cancer | View |
| None | Non-small cell lung cancer | View |
| None | Melanoma | View |
| None | TSR-033 | View |
| None | TSR-042 | View |
| None | Hepatocellular carcinoma cancer | View |
| None | Docetaxel | View |